2019
DOI: 10.1176/appi.ajp.2019.18091033
|View full text |Cite
|
Sign up to set email alerts
|

Brain Imaging of the Cortex in ADHD: A Coordinated Analysis of Large-Scale Clinical and Population-Based Samples

Abstract: Sunovian. He is/has been involved in clinical trials conducted by Lilly & Shire. The present work is unrelated to the above grants and relationships. Jonna Kuntsi has given talks at educational events sponsored by Medice; all funds are received by King's College London and used for studies of ADHD. Theo Van Erp consulted for Roche Pharmaceuticals and has a contract with Otsuka Pharmaceutical, Ltd. Anders Dale is a Founder of CorTechs Labs, Inc. He serves on the Scientific Advisory Boards of CorTechs Labs and H… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

20
290
3
9

Year Published

2019
2019
2024
2024

Publication Types

Select...
5
2
1

Relationship

3
5

Authors

Journals

citations
Cited by 349 publications
(322 citation statements)
references
References 52 publications
20
290
3
9
Order By: Relevance
“…Any interpretation of the cross-disorder sMRI correlations must keep in mind that, for all disorders, the case-control differences in sMRI measures are small ( Figure 1). The largest Cohen's D values are only -0.5 for SCZ (19,20), -0.4 for epilepsy (14), -0.3 for BD (12,13), -0.2 for ADHD (9,10) and ASDs (11), and -0.1 for MDD (15,16) and OCD (17,18). These small case-control differences are consistent with results from GWAS and environmental risk studies, which speaks to the fact that the effects of common risk factors are, with some rare exceptions, individually small.…”
Section: Discussionmentioning
confidence: 94%
See 2 more Smart Citations
“…Any interpretation of the cross-disorder sMRI correlations must keep in mind that, for all disorders, the case-control differences in sMRI measures are small ( Figure 1). The largest Cohen's D values are only -0.5 for SCZ (19,20), -0.4 for epilepsy (14), -0.3 for BD (12,13), -0.2 for ADHD (9,10) and ASDs (11), and -0.1 for MDD (15,16) and OCD (17,18). These small case-control differences are consistent with results from GWAS and environmental risk studies, which speaks to the fact that the effects of common risk factors are, with some rare exceptions, individually small.…”
Section: Discussionmentioning
confidence: 94%
“…Furthermore, for some of the disorders, we could use youth and adult data, whereas for others only adult effect data were used. Because findings can differ substantially depending on the age range of the samples included (e.g., (9,10,17,18)), this might have influenced our findings. For these reasons, analyses of participant level data will be needed to address these issues to draw stronger and more detailed conclusions.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Fourth, the resolution of the fMRI images is sub‐optimal (3.75 × 3.75 × 4.55 mm) compared to the newer multi‐band sequences (2–3 mm isotropic). In addition, there are some existing large N datasets, for example, ENIGMA (Favre et al, ; Hoogman et al, ; van Velzen et al, ), 10 K in 1 day (van den Heuvel et al, ) and morphometric similarity networks (Seidlitz et al, ), which introduce several new network features that can be used to investigate age‐related variations in both healthy as well as disease.…”
Section: Discussionmentioning
confidence: 99%
“…Imaging studies, including meta-analyses, have generally compared one of the three disorders to healthy controls (8)(9)(10)(11)(12). Large-scale studies generally yielded small to moderate effect sizes, indicating that disorder-associated alterations are subtle (13)(14)(15)(16)(17). Few structural imaging studies have directly compared these three disorders (18,19), mostly in small numbers and with inconsistent results (20).…”
Section: Introductionmentioning
confidence: 99%